Mundisal (Choline Salicylate)

Choline salicylate inhibits cyclooxygenase enzymes in peripheral tissues, which lowers prostaglandin production. This reduction diminishes inflammation and pain signaling, resulting in a localized analgesic and anti‑inflammatory effect when the product is applied to the skin.

The specific amount and frequency of application are determined by the prescribing health professional. Typically, a thin layer is applied to the affected area as directed, but the exact regimen should follow the prescriber’s instructions.

Safety data for choline salicylate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using Mundisal to assess potential risks.

To request Mundisal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mundisal contains choline salicylate, a salicylate‑based NSAID, offering similar anti‑inflammatory and analgesic effects to other topical NSAIDs such as diclofenac gel. Choice between products often depends on formulation preferences, tolerability, and specific clinical guidance from a healthcare professional.

Mundisal should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, direct sunlight and excessive heat to maintain product stability.

Mundisal is applied externally to clean, dry skin. A thin layer is spread over the affected area and gently massaged until absorbed. Hands should be washed after use, and the product should not be applied to broken skin, eyes or mucous membranes.

Serious risks, though rare, include allergic reactions such as hives, swelling, or difficulty breathing, and severe dermatitis with blistering. Systemic salicylate toxicity can occur with excessive use, presenting with tinnitus, nausea or dizziness. Seek medical attention if any of these symptoms appear.

Mundisal should be avoided by individuals with known hypersensitivity to salicylates or any component of the formulation, those with open wounds or infected skin at the application site, and patients using other topical NSAIDs concurrently without professional guidance.